Home/Publication/Cowin Doubles Down on Flu Antivirals Developer
Cowin Doubles Down on Flu Antivirals Developer 

27 Jun 2024

US$ 19.00

Cowin Capital has made a follow-on investment in the over Rmb200 million (US$27.5 million) series A funding round of ......

Price / article: US$19.00
OR existing subscriber
Related Publications

KKR & Co Inc (KKR) has sold its 22.2% stake in PT Nippon Indosari Corpindo Tbk, the operator of Sari Tori, and ......

MARS Growth Capital (MARS) and HSBC Holdings Plc (HSBC) have led a US$150 m refinancing for Eruditus Executive ......

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.